Clinical Oncology Research Testing

Clinical Oncology Research Testing

What is my anti-tumor ability?

  1. Is my ability to fight the tumor directly enough?

  2. Has my anti-tumor ability been damaged by chemotherapy and other treatments?

  3. Is the anti-tumor function of T cells shut down by the tumor?

  4. If I want to do immune cell therapy, can I do it?

  5. What kind of immune cell therapy can still help me fight cancer?

  6. Too many immune cells will not help and may cause tumor proliferation!

  7. Can I have immunotherapy to fight against tumor if I have allergy?

  8. Are immunosuppressive point suppressants effective? Do I need to change the medication?

  9. What should I do next? Are there any drugs that can help me?

  10. Can I do immunotherapy directly after the tumor is removed?

Learn more about your immune system's ability to fight tumors

Test Features : CIP002

  1. The world's first systemic immune system test

  2. The world's most advanced cell analysis technology and equipment

  3. complete anti-tumor capacity report

  4. readily available as an adjunct to surgery, radiotherapy, chemotherapy and other therapies

  5. serve as the best reference for immune cell status in the anti-tumor process

  6. as a reference for autologous selection of the best immune cells for treatment

  7. as a basis for future allogeneic immune cell therapy

  8. as a reference for the timing of immunosuppressive site inhibitors

  9. Special immune cell detection, such as γ-δ cell, DC cell detection, etc.

  10. 3~5 days for rapid report

Test Report:

  1. Immune cell composition and ratio

  2. Comparison of the average number of immune cells

  3. Evaluation of anti-tumor capacity status

  4. Overall assessment of various indices

  5. Risk Assessment                              

  6. Clinician Support System